Bio2brain

bio2brain - nose-to-brain delivery of biopharmaceutics for the therapy of central nervous system diseases: a design-based approach for efficient drug delivery systems the bio2brain project is an eu-funded project that launched in january 2021. the aim of the bio2brain network is the development of a research and training program to train young scientists in innovating novel technologies to deliver biopharmaceuticals efficiently from the nose to the brain. it thereby offers a unique opportunity to 13 early career researchers to develop new paradigms and treatments in neurological diseases. bio2brain will create the fundament for the future transfer of the developed technologies for a later clinical development and gmp manufacturing. this project has received funding from the european union’s horizon 2020 research and innovation programme under the marie skłodowska-curie grant agreement no 956977.